LSRCX | VSCAX | LSRCX / VSCAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 26 years | - |
Gain YTD | 2.105 | 4.892 | 43% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 404M | 6.68B | 6% |
Annual Yield % from dividends | 0.66 | 0.48 | 139% |
Returns for 1 year | -35.85 | 25.28 | -142% |
Returns for 3 years | -48.75 | 30.32 | -161% |
Returns for 5 years | -65.09 | 74.58 | -87% |
Returns for 10 years | -89.63 | 35.60 | -252% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFARX | 38.62 | 0.40 | +1.05% |
JHancock Fundamental All Cap Core R4 | |||
WRLDX | 35.61 | 0.23 | +0.65% |
Scharf Global Opportunity Institutional | |||
JAAGX | 86.17 | 0.10 | +0.12% |
Janus Henderson VIT Enterprise Instl | |||
SHSSX | 69.32 | N/A | N/A |
BlackRock Health Sciences Opps Instl | |||
GVIZX | 11.99 | N/A | N/A |
GuideStone Funds Value Equity Index Inv |